Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raseglurant for Migraine Prevention
NCT00820105Phase 2Terminated
- Sponsor
- Addex Therapeutics Ltd
- Start
- Dec 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of raseglurant in migraine, sponsored by Addex Therapeutics Ltd. Started Dec 2008; status: terminated.
02
Drugs
raseglurant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00820105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00820105.